Arrowgrass Capital Partners (US)’s Celgene Corp CELG Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,002,964	Closed	-$92.7M	–	356
2019 Q2	$92.7M	Buy	1,002,964 +480,062	+92%	+$45.6M	2.2%	5
2019 Q1	$49.3M	Buy	+522,902	New	+$45.7M	1.45%	9
2018 Q1	–	Sell	-19,945	Closed	-$2.08M	–	549
2017 Q4	$2.08M	Buy	+19,945	New	+$2.25M	0.02%	383
2017 Q2	–	Sell	-47,792	Closed	-$5.86M	–	669
2017 Q1	$5.95M	Buy	+47,792	New	+$5.72M	0.06%	314
2016 Q4	–	Sell	-2,524	Closed	-$281K	–	592
2016 Q3	$264K	Sell	2,524 -7,748	-75%	-$839K	﹤0.01%	420
2016 Q2	$1.01M	Buy	+10,272	New	+$1.06M	0.01%	341
2015 Q4	–	Sell	-881	Closed	-$95K	–	510
2015 Q3	$95K	Sell	881 -54,353	-98%	-$6.75M	﹤0.01%	440
2015 Q2	$6.39M	Buy	+55,234	New	+$6.31M	0.1%	184
2014 Q1	–	Sell	-30,000	Closed	-$2.54M	–	232
2013 Q4	$2.54M	Buy	+30,000	New	+$2.37M	0.12%	115

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s CELG Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 1,002,964 shares — an estimated $92.7M sold.

Arrowgrass Capital Partners (US) first reported a position in CELG in Q4 2013 and held it in 9 quarters. The position peaked at $92.7M in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

Arrowgrass Capital Partners (US) reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 1,002,964 Celgene Corp shares in Q3 2019, an estimated $92.7M.
Arrowgrass Capital Partners (US) first reported a position in Celgene Corp in Q4 2013 and held it in 9 quarters.
Arrowgrass Capital Partners (US)'s Celgene Corp position peaked at $92.7M in Q2 2019.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.